Capabilities

Our firm serves a broad range of public and private companies, ranging from emerging biotechnology and medical device companies to established pharmaceutical leaders. We also work with venture capitalists and institutional investors that provide capital to these companies. If you would like to receive a copy of our capabilities brochure, please send your request to info@mdbpartners.com and be sure to include your complete contact information.

Investor and Public Relations

  • Financial, Media and Public Relations
  • Communications and Writing Services
  • Crisis and Issues Management
  • Disclosure Procedures and Compliance
  • New, Digital and Social Media

Strategic
Advisory

  • Corporate Strategy and Brand Positioning
  • Business Development
  • Outsourced Due Diligence
  • Corporate Funding
  • Market Research

Operational Improvement

  • Workout and Corporate Reorganization
  • Interim and Acting Management Solutions
  • Turnaround and Targeted Improvement
  • Project Management
  • Supplementing In-house Staff

areas of expertiseWe have extensive clinical, commercial, and regulatory experience along with strong relationships in the following areas...

Therapeutics: Signal transduction inhibitors, monoclonal antibodies, immunotherapies, radiopharmaceuticals, tissue engineering, gene therapy, and stem cells.

Supportive Care: Pain palliation, oral mucositis, xerostomia, and cutaneous reactions arising from radiation therapy, chemotherapy, and targeted agents such as inhibitors of the epidermal growth factor receptor (EGFR).

510(k) Devices: Point-of-care in vitro diagnostic tests and prescription medical devices.

Imaging and Diagnostics: Radiopharmaceuticals, contrast agents for magnetic resonance imaging (MRI), and molecular diagnostics.

Technology Platforms: Proteomics, phage display, and epigenetics.